Content
All Posts > Content under Healthcare
Genocea Biosciences, Inc. Shares Crash As Company Announces Layoffs & Shift In Drug Development Strategy
Article By:
TickerTV
Read
Wednesday, September 27, 2017 11:36 AM EDT
GNCA opened trading yesterday at $5.24 which was down from the previous day’s trading close of $5.29. Shares closed trading yesterday at $5.33 and spiked down aftermarket to $2.70, equivalent to a 49% decrease from the closing price.
In this article: GNCA
Apple, Fitbit Among Nine Selected For FDA Digital Pilot Program
Bull Of The Day: Edwards Lifesciences (EW)
Article By:
Kevin Cook
Read
Monday, September 25, 2017 10:04 AM EDT
The 2018 profit projection moved up to $4.17 from $3.97, representing 10% growth and matching the annual revenue growth rate as sales are expected to climb to $3.74 billion from this year's $3.4 billion.
In this article: EW
On The Fly: Top Five Weekend Stock Stories - Monday, September 25
Week In Review: How Trump's Policies Moved Stocks - Sunday, September 24
Above The 40 – Apple Falls From The Tree, The Stock Market Bends Without Breaking
Weighing The Week Ahead: Time For Tax Reform?
Article By:
Jeff Miller
Read
Sunday, September 24, 2017 3:34 AM EDT
On the economic calendar, most important are personal income and spending, also new home sales and the consumer confidence data. There are plenty of Fed participants on the rubber chicken circuit. The GOP tax proposal will take center stage.
42 Firms Going Ex-Dividend Next Week, Including Philip Morris, Cardinal Health And State Street
Article By:
Timothy J. McIntosh
Read
Friday, September 22, 2017 8:57 PM EDT
There are several well known large cap stocks going ex-dividend next week including the following six Top 100 Dividend Stocks: Philip Morris Int’l, Agrium, Chubb Limited, Medtronic, Cardinal Health and State Street Corp.
Three Overbought Canadian LP's To Watch
Article By:
Technical420
Read
Thursday, September 21, 2017 8:54 AM EDT
Canadian licensed medical marijuana producers were under pressure yesterday and we are monitoring how this trend continues today.
Pfizer Takes J&J To Court As Analysts Shake Up Pharma Ratings
Epizyme Announces Closing Of Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Tuesday, September 19, 2017 10:19 AM EDT
Epizyme, Inc., today announced the closing of its public offering of 10,557,000 shares of its common stock at a price of $15.25 per share, before underwriting discounts.
In this article: EPZM